Pharmacists play a central role in monitoring, counseling on, and facilitating access to GLP-1 RAs, thereby supporting optimal clinical outcomes and therapy tolerability
Retatrutide-related nausea, vomiting, diarrhea, or reduced food and fluid intake can also increase the risk of dehydration
The most common adverse effects are gastrointestinal: nausea, stomach discomfort, or diarrhea
The strongest evidence we have comes from two meta-analyses, types of studies that pool together and analyse the results of other studies
This inconsistency might be due to most trials being small, short-term, and not specifically designed for hypertension assessment
Induction by interferon-gamma and contribution to ATP-dependent proteolysis